Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Vigabatrin in childhood epilepsy: a 5-year follow-up study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Hypomyelinating Leukodystrophy due to HSPD1 Mutations: A New Patient

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Variant of Rett Syndrome and CDKL5 Gene: Clinical and Autonomic Description of 10 Cases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Brain malformation in single median maxillary central incisor

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Continuing decline in the prevalence of cerebral palsy in Denmark for birth years 2008–2013

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Increase in cognitive function is seen in many single-operated pediatric patients after epilepsy surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Children with dyskinetic cerebral palsy are severely affected as compared to bilateral spastic cerebral palsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Infections seem to be more frequent before onset of pediatric multiple sclerosis: A Danish nationwide nested case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. The landscape of epilepsy-related GATOR1 variants

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
In an retrospective uncontrolled long-term study in 30 children with intractable epilepsy, it was found that treatment with vigabatrin resulted in a seizure reduction of more than 50% at 1-year follow-up in 40% of the children. The responders were all children with partial seizures. Side effects were mild and did not lead to discontinuation of the drug. Increased numbers of seizures were seen in three cases. A moderate weight increase was seen in 27% of the children. At 5-year follow-up 7 children (23%) still maintained a seizure reduction of more than 50%. Trials of monotherapy in three seizure-free patients were unsuccessful. No further side effects were observed. A study of evoked potentials in 12 children showed no alteration in latency and amplitudes of VEP following treatment with vigabatrin. Our results show that in children vigabatrin seems to have a stable effect even though a few children may experience a breakthrough of seizures. The presented results together with previous reports on MRI-scans seem to indicate that even in children with a still maturing CNS vigabatrin is a safe drug.
OriginalsprogEngelsk
TidsskriftNeuropediatrics
Vol/bind26
Udgave nummer5
Sider (fra-til)253-6
Antal sider4
ISSN0174-304X
DOI
StatusUdgivet - 1995

ID: 36737296